Session Information
AABB Audioconference Series 2013
Click here to go to the previous page
Mobilization with Plerixafor (Mozobil) — Why, When and How
Track : Cellular Therapy
Program Code: 134767
Date: Wednesday, December 18, 2013
Time: 2:00 PM to 3:30 PM  EST
DIRECTOR :
Joseph Schwartz, MD, MPH
MODERATOR :
Joseph Schwartz, MD, MPH
SPEAKER (S):
Abba Zubair, MD, PhD
Impact of Plerixafor on HPC Mobilization
Michele Cottler-Fox, MD, Director, Cell Therapy and Transfusion Medicine, UAMS
Towards Optimizing Use of Plerixafor Using a Predictive Formula
Description
This audio conference will describe the mechanism of action of Plerixafor (Mozobil) and will look at its current use. Algorthims for the incorporation of Plerixafor (Mozobil) in the mobilization of peripheral blood HPCs will be shared with the audience. A predictive formula to target the need for Plerixafor (Mozobil) and its use in the most cost —effective way will be presented.

You will have the ability to purchase CD-ROMs of this Audioconference 2 weeks after the session has been presented. For any questions, please contact MultiviewMediaSupport@multiview.com.

  • Mobilization using Plerixafor (Mozobil)-current evidence.
  • Understand cost effective aspects associated with Plerixafor (Mozobil) mobilization
  • Understand predictabilty models for mobilization with/without Plerixafor (Mozobil).
  • Understand principles of mobilization with Plerixafor (Mozobil).


CE CategoryCE Value
California Clinical Laboratory Personnel 1.5
California Nurse 1.8
Florida Laboratory Personnel 1.8
General Attendee 1.5
Physician 1.5
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.


Fed-Ex is only available for orders made within North America


Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are
the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text
are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or
reproduction of any materials herein is strictly prohibited.